JFS Wealth Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61 | Hold |
3
| – | – | ﹤0.01% | 2226 |
|
|
2026
Q1 | $49 | Hold |
3
| – | – | ﹤0.01% | 1863 |
|
|
2025
Q4 | $51 | Hold |
3
| – | – | ﹤0.01% | 1902 |
|
|
2025
Q3 | $47 | Hold |
3
| – | – | ﹤0.01% | 1871 |
|
|
2025
Q2 | $39 | Hold |
3
| – | – | ﹤0.01% | 1839 |
|
|
2025
Q1 | $39 | Hold |
3
| – | – | ﹤0.01% | 1908 |
|
|
2024
Q4 | $40 | Hold |
3
| – | – | ﹤0.01% | 1915 |
|
|
2024
Q3 | $46 | Hold |
3
| – | – | ﹤0.01% | 1930 |
|
|
2024
Q2 | $43 | Hold |
3
| – | – | ﹤0.01% | 1963 |
|
|
2024
Q1 | $41 | Hold |
3
| – | – | ﹤0.01% | 1984 |
|
|
2023
Q4 | $41 | Hold |
3
| – | – | ﹤0.01% | 1981 |
|
|
2023
Q3 | $38 | Hold |
3
| – | – | ﹤0.01% | 1938 |
|
|
2023
Q2 | $41 | Hold |
3
| – | – | ﹤0.01% | 1956 |
|
|
2023
Q1 | $42 | Hold |
3
| – | – | ﹤0.01% | 1929 |
|
|
2022
Q4 | $43 | Hold |
3
| – | – | ﹤0.01% | 1928 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1812 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1829 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1885 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1784 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 840 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 615 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 606 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 599 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 575 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 547 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 529 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 530 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 526 |
|
|
2019
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 472 |
|
|
2019
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 469 |
|
|
2018
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 492 |
|
|
2018
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 534 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 507 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 548 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 542 |
|
|
2017
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 451 |
|
|
2017
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 429 |
|
|
2017
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 442 |
|
|
2016
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 464 |
|
|
2016
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 500 |
|
|
2016
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 550 |
|
|
2016
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 645 |
|
|
2015
Q4 | $0 | Buy |
+3
| New | +$74 | ﹤0.01% | 551 |
|
Other funds holding HQL
1WA
FAM
PFO
DI
IFG
MFG
WAP
SFS
CA
JFS Wealth Advisors's HQL Position: Q2 2026 in Review
JFS Wealth Advisors held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 3 shares worth $61. The position accounts for ﹤0.01% of the portfolio, ranked #2226.
JFS Wealth Advisors first reported a position in HQL in Q4 2015 and has held it in 43 quarters since. 12 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- JFS Wealth Advisors held 3 shares of abrdn Life Sciences Investors worth $61 as of Q2 2026.
- JFS Wealth Advisors left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
- abrdn Life Sciences Investors made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2226 holding.
- JFS Wealth Advisors first reported a position in abrdn Life Sciences Investors in Q4 2015 and has held it in 43 quarters since.
- 12 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.